INFUSION OF NON-HLA MATCHED, OFF-THE-SHELF EX VIVO EXPANDED CORD BLOOD PROGENITOR CELLS IN PATIENTS UNDERGOING MYELOABLATIVE CORD BLOOD TRANSPLANTATION IS SAFE AND DECREASES THE TIME TO NEUTROPHIL RECOVERY

被引：5
|
作者：
Delaney, C. [1 ,2 ]
Milano, F. [1 ]
Shelly, H. [1 ]
Nicoud, I [1 ]
Bernstein, I. D. [1 ,2 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Sch Med, Seattle, WA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2012年 / 18卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2011.12.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4
引用
收藏
页码：S203 / S203
页数：1
相关论文
共 36 条
  • [31] Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation
    M E Bernardo
    L M Ball
    A M Cometa
    H Roelofs
    M Zecca
    M A Avanzini
    A Bertaina
    L Vinti
    A Lankester
    R Maccario
    O Ringden
    K Le Blanc
    R M Egeler
    W E Fibbe
    F Locatelli
    Bone Marrow Transplantation, 2011, 46 : 200 - 207
  • [32] Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lymphoma
    Nieto, Yago
    Banerjee, Pinaki
    Kaur, Indresh
    Kim, Kun Hee
    Fang, Dexing
    Thall, Peter F.
    Griffin, Lori
    Barnett, Melissa
    Basar, Rafet
    Hosing, Chitra
    Ramdial, Jeremy
    Srour, Samer
    Daher, May
    Marin, David
    Jiang, Xianli
    Chen, Ken
    Champlin, Richard
    Shpall, Elizabeth J.
    Rezvani, Katayoun
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (02): : 203e1 - 203e9
  • [33] A Phase 1 Dose Escalation Study of Infusion of Ex Vivo CD3/CD28 Costimulated Umbilical Cord Blood-Derived T Cells in Adults Undergoing Transplantation for Advanced Hematologic Malignancies
    Hexner, Elizabeth
    Luger, Selina M.
    Mangan, James K.
    Frey, Noelle V.
    Jeschke, Grace R.
    Frank, Dale
    Reshef, Ran
    Loren, Alison W.
    Goldstein, Steven C.
    Rosenbach, Misha
    Nowaczyk, Christopher
    Schuster, Mindy
    Stadtmauer, Edward A.
    Levine, Bruce L.
    June, Carl H.
    Emerson, Stephen G.
    Porter, David L.
    BLOOD, 2011, 118 (21) : 1307 - 1307
  • [34] A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord® [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD
    Parikh, Suhag
    Brochstein, Joel A.
    Wease, Stephen
    Martin, Paul L.
    Horwitz, Mitchell E.
    Schwarzbach, Aurelie
    Kurtzberg, Joanne
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S157 - S158
  • [35] Strategy to combat opportunistic infections after umbilical cord blood transplantation (UCBT) - Monitoring of multiple pathogens with a novel multiplex PCR system and infusion of ex-vivo expanded CD4 T-CELLS (CD4-DLI)
    Morio, Tomohiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (11) : 1400 - 1401
  • [36] StemEx®(Copper Chelation Based) Ex Vivo Expanded Umbilical Cord Blood Stem Cell Transplantation (UCBT) Accelerates Engraftment and Improves 100 Day Survival In Myeloablated Patients Compared To a Registry Cohort Undergoing Double Unit UCBT: Results Of a Multicenter Study Of 101 Patients With Hematologic Malignancies
    Stiff, Patrick J.
    Montesinos, Pau
    Peled, Tony
    Landau, Efrat
    Rosenheimer, Noga
    Mandel, Julie
    Hasson, Nira
    Olesinski, Esti
    Glukhman, Ela
    Snyder, David A.
    Galamidi, Einat
    Kidron, Orna Srur
    Bracha, Dalia
    Harati, Dorit
    Ben-Abu, Keren
    Freind, Etty
    Freedman, Laurence
    Cohen, Yael C.
    Olmer, Liraz
    Barishev, Raya
    Rocha, Vanderson
    Horowitz, Mary M.
    Eapen, Mary
    Nagler, Arnon
    Sanz, Guillermo
    BLOOD, 2013, 122 (21)
1234